Your browser doesn't support javascript.
loading
Clinical and genetic features of IL12Rb1 deficiency: Single center experience of 18 patients.
Tan, Çagman; Çagdas-Ayvaz, Deniz; Metin, Ayse; Keskin, Özlem; Tezcan, Ilhan; Sanal, Özden.
Afiliação
  • Tan Ç; Division of Immunology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara.
  • Çagdas-Ayvaz D; Division of Immunology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara.
  • Metin A; Diskapi Children's Hospital, Ankara.
  • Keskin Ö; Division of Immunology and Allergy, Department of Pediatrics, Gaziantep University Faculty of Medicine, Gaziantep Turkey.
  • Tezcan I; Division of Immunology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara.
  • Sanal Ö; Division of Immunology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara.
Turk J Pediatr ; 58(4): 356-361, 2016.
Article em En | MEDLINE | ID: mdl-28276206
Mendelian susceptibility to mycobacterial disease (MSMD) is characterized by infections with weakly virulent mycobacteria (BCG and environmental mycobacteria), M. tuberculosis, Salmonella, candida and some other intracellular microorganisms. Nine different genetic defects have been defined to cause MSMD and IL-12Rß1 deficiency is the most common form. We present here the clinical and genetic features of 18 patients with IL12Rß1 deficiency diagnosed by surface expression of IL-12Rß1 and Sanger's sequencing. Seventeen patients showed classical presentation (infections with BCG, salmonella and candida) while one patient experienced recurrent leishmaniasis. In all patients the percentage of activated lymphocytes with surface expression of IL12Rß1 was < 1% indicating that it is an effective method for the screening of these patients. Three recurrent mutations were responsible for 85% of our families. Prognosis was good in patients, in whom specific antimicrobial therapy was given before dissemination occurs, as well as prophylactic antimicrobial treatment when needed and IFN-γ therapy for severe infectious episodes.
Assuntos
Palavras-chave
Buscar no Google
Base de dados: MEDLINE Assunto principal: Receptores de Interleucina-12 / Mycobacterium tuberculosis Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Receptores de Interleucina-12 / Mycobacterium tuberculosis Idioma: En Ano de publicação: 2016 Tipo de documento: Article